The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

The lawsuit is the result of a sweeping investigation that dates back years. In the course of the investigation, which Visa ...

As a possible indication that the hearing, which starts at 10a ET, could get contentious, it has the title, "Why is Novo ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

The agency plans to argue that the company illegally penalizes customers that try to use rival payment processors.

The disparity between patients with public and private insurance may play into a further inequality of prenatal diagnoses of ...

The original developers of insulin deemed it unethical to profit off the life-saving therapeutic, selling the patent to the University of Toronto for just $1 in 1923. For the last 25 years, PBMs ...

Deteriorating conditions can send people to the ER with falls and injuries. And toxic pollutants contribute to health ...

Israel Launches Airstrikes on Hezbollah, Killing at Least 270 in Lebanon It was the deadliest day of Israeli attacks in Lebanon since at least 2006. The Lebanese health ministry said over 1,000 ...